CAR-T Trials Boast Promising Results – The Scientist
|
CAR–T Trials Boast Promising Results
The Scientist Multiple myeloma cellsWIKIMEDIA, KGHNanjing Legend Biotech's chimeric antigen receptor T–cell (CAR-T) therapy induced some level of remission within two months in 33 of 35 multiple myeloma patients in an ongoing clinical trial, according to results … |
